Health Care & Life Sciences » Biotechnology | International Stem Cell Corp.

International Stem Cell Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,293.00
1,161.00
532.00
110.00
304.00
1,075
Total Accounts Receivable
306.00
453.00
539.00
574.00
465.00
651
Inventories
1,369.00
1,517.00
1,348.00
1,390.00
1,307.00
1,501
Other Current Assets
658.00
485.00
572.00
418.00
779.00
543
Total Current Assets
4,626.00
3,616.00
2,991.00
2,492.00
2,855.00
3,770
Net Property, Plant & Equipment
830.00
714.00
375.00
396.00
321.00
469
Intangible Assets
2,250.00
2,795.00
3,223.00
3,484.00
2,922.00
2,674
Other Assets
33.00
54.00
549.00
673.00
766.00
883
Total Assets
7,739.00
7,179.00
7,138.00
7,045.00
6,864.00
7,796
ST Debt & Current Portion LT Debt
-
-
3,110.00
-
-
Accounts Payable
532.00
670.00
1,092.00
841.00
830.00
Other Current Liabilities
6,489.00
6,188.00
1,342.00
2,760.00
3,970.00
Total Current Liabilities
7,021.00
6,858.00
5,544.00
3,601.00
4,800.00
Total Liabilities
7,021.00
6,858.00
5,544.00
3,601.00
4,800.00
Common Equity (Total)
4,223.00
316.00
1,589.00
3,439.00
2,059.00
Total Shareholders' Equity
718.00
321.00
1,594.00
3,444.00
2,064.00
Total Equity
718.00
321.00
1,594.00
3,444.00
2,064.00
Liabilities & Shareholders' Equity
7,739.00
7,179.00
7,138.00
7,045.00
6,864.00
Preferred Stock (Carrying Value)
4,941.00
5.00
5.00
5.00
5.00

About International Stem Cell

View Profile
Address
5950 Priestly Drive
Carlsbad California 92008
United States
Employees -
Website http://www.internationalstemcell.com
Updated 07/08/2019
International Stem Cell Corp. is a biotechnology company, which in the development of biomedical products. It operates through the following segments: Cosmetic Market; Biomedical Market; and Therapeutic Market. The Cosmetic Market segment focuses in the skincare producs.